---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-075387"
form_type: "8-K"
ticker: "RZLT"
cik: "0001509261"
company_name: "Rezolute, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T00:59:11.710145+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Rezolute raises ~$67M through public offering and concurrent private placement

## Summary
- Underwriters exercised over-allotment option for 1,786,589 shares at $4.00 each.
- Total offering: 13,036,589 shares plus pre-funded warrants for 3.75M shares; gross proceeds ~$67M.
- Concurrent private placement of 1.5M shares at $4.00/share for ~$6M in additional gross proceeds.
- Net proceeds will fund clinical R&D (RZ358 for hyperinsulinism) and working capital.
- Jefferies and Cantor acted as joint book-running managers for the public offering.

## SEC filing metadata
- accession: 0001104659-24-075387
- form_type: 8-K
- ticker: RZLT
- cik: 0001509261
- company_name: Rezolute, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509261/000110465924075387/0001104659-24-075387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509261/000110465924075387/tm2418270d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-075387
- JSON: https://secwatch.observer/filing/0001104659-24-075387.json
- Plain text: https://secwatch.observer/filing/0001104659-24-075387.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.